Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Long-term treatment of systemic lupus erythematosus (SLE) with hydroxychloroquine, initiated soon after disease onset, is protective against renal damage, according to study findings…
NEW YORK (Reuters Health) – Patients who use statins prior to hospitalization for pneumonia are less likely to die after discharge than their peers who were not using…
NEW YORK (Reuters Health) – If aspirin is to be used routinely for primary prevention of cardiovascular disease, it should begin at age 48 in men and 57…
NEW YORK (Reuters Health) – The platelet inhibition caused by clopidogrel is reduced when the drug is coadministered with calcium-channel blockers, Austrian researchers report. Dr. Bernd Jilma and…
NEW YORK (Reuters Health) – An infusion of dexamethasone-loaded autologous erythrocytes appears to be an effective treatment for mild-to-moderate ulcerative colitis that is refractory to mesalamine, new research…
NEW YORK (Reuters Health) – Beta-blocker-induced heart rate lowering has been shown to have beneficial effects in patients with MI and heart failure, but findings from a new…
NEW YORK (Reuters Health) – As a treatment for early multiple sclerosis, alemtuzumab, an antibody that targets CD52 on lymphocytes and monocytes, is more effective than interferon beta-1a,…
NEW YORK (Reuters Health) – In combination with methotrexate, tocilizumab, an IL-6 receptor inhibitor, can safely improve the signs and symptoms of rheumatoid arthritis in patients with an…
NEW YORK (Reuters Health) – Measuring procalcitonin levels, which are relatively high with bacterial versus viral infections, can help reduce antibiotic use in treating respiratory tract infections, according…
